Search research articles
Contact Us
Filters
Showing results (331-340 of 663) with videos related to
Page
of 67
Sort By:
Journal of Virology
|
August 13, 2010
A maraviroc-resistant HIV-1 with narrow cross-resistance to other CCR5 antagonists depends on both N-terminal and extracellular loop domains of drug-bound CCR5
John C Tilton, Craig B Wilen, Chukwuka A Didigu, et al.
The Journal of Infectious Diseases
|
March 7, 2009
Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection
Wei Jiang, Michael M Lederman, Peter Hunt, et al.
AIDS Research and Human Retroviruses
|
August 15, 2009
Characterization of human immunodeficiency virus type 1 populations containing CXCR4-using variants from recently infected individuals
Wei Huang, Jonathan Toma, Eric Stawiski, et al.
Plos One
|
October 24, 2025
Case-control study of autonomic symptoms in the setting of Long COVID with tilt table testing
Matthew S Durstenfeld, Nirosh Mataraarachchi, Michael J Peluso, et al.
Plos One
|
August 11, 2012
Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection
Christopher E Ormsby, Devi Sengupta, Ravi Tandon, et al.
AIDS Research and Human Retroviruses
|
May 3, 2014
Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers
Ravi Tandon, Glen M Chew, Mary M Byron, et al.
Plos One
|
October 24, 2014
CD4+ and CD8+ T cell activation are associated with HIV DNA in resting CD4+ T cells
Leslie R Cockerham, Janet D Siliciano, Elizabeth Sinclair, et al.
AIDS (London, England)
|
September 10, 2003
Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy
Peter W Hunt, Steven G Deeks, Benigno Rodriguez, et al.
Blood
|
February 4, 2011
Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression
Adam R Hersperger, Jeffrey N Martin, Lucy Y Shin, et al.
Blood
|
August 17, 2004
Expansion of CD7(low) and CD7(negative) CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment
Einar M Aandahl, Máire F Quigley, Walter J Moretto, et al.
Page
of 67
Search research articles
Search
Showing results (331-340 of 663) with videos related to
Sort By:
Page
of 67
Journal of Virology
|
August 13, 2010
A maraviroc-resistant HIV-1 with narrow cross-resistance to other CCR5 antagonists depends on both N-terminal and extracellular loop domains of drug-bound CCR5
John C Tilton, Craig B Wilen, Chukwuka A Didigu, et al.
The Journal of Infectious Diseases
|
March 7, 2009
Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection
Wei Jiang, Michael M Lederman, Peter Hunt, et al.
AIDS Research and Human Retroviruses
|
August 15, 2009
Characterization of human immunodeficiency virus type 1 populations containing CXCR4-using variants from recently infected individuals
Wei Huang, Jonathan Toma, Eric Stawiski, et al.
Plos One
|
October 24, 2025
Case-control study of autonomic symptoms in the setting of Long COVID with tilt table testing
Matthew S Durstenfeld, Nirosh Mataraarachchi, Michael J Peluso, et al.
Plos One
|
August 11, 2012
Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection
Christopher E Ormsby, Devi Sengupta, Ravi Tandon, et al.
AIDS Research and Human Retroviruses
|
May 3, 2014
Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers
Ravi Tandon, Glen M Chew, Mary M Byron, et al.
Plos One
|
October 24, 2014
CD4+ and CD8+ T cell activation are associated with HIV DNA in resting CD4+ T cells
Leslie R Cockerham, Janet D Siliciano, Elizabeth Sinclair, et al.
AIDS (London, England)
|
September 10, 2003
Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy
Peter W Hunt, Steven G Deeks, Benigno Rodriguez, et al.
Blood
|
February 4, 2011
Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression
Adam R Hersperger, Jeffrey N Martin, Lucy Y Shin, et al.
Blood
|
August 17, 2004
Expansion of CD7(low) and CD7(negative) CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment
Einar M Aandahl, Máire F Quigley, Walter J Moretto, et al.
Page
of 67